Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 337

3.

New threats to the control of methicillin-resistant Staphylococcus aureus.

Casewell MW.

J Hosp Infect. 1995 Jun;30 Suppl:465-71.

PMID:
7560985
4.

Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.

Sakoulas G, Moellering RC Jr.

Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S360-7. doi: 10.1086/533592. Review.

5.

Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.

Atahan E, Gul M, Ergun Y, Eroglu E.

Eur J Vasc Endovasc Surg. 2007 Aug;34(2):182-7. Epub 2007 May 4.

6.

Comparative in vitro activity of vancomycin and other antimicrobial agents against methicillin-resistant staphylococcus aureus and enterococcus faecium in the Tohoku district of Japan.

Lutfor AB, Kikuchi T, Tokue Y, Takahashi H, Shoji S, Fujimura S, Nukiwa T, Watanabe A.

Chemotherapy. 1998 Sep-Oct;44(5):318-23.

PMID:
9732146
7.

Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis.

Aldeyab MA, Monnet DL, López-Lozano JM, Hughes CM, Scott MG, Kearney MP, Magee FA, McElnay JC.

J Antimicrob Chemother. 2008 Sep;62(3):593-600. doi: 10.1093/jac/dkn198. Epub 2008 May 7.

8.

Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.

Bal AM, Gould IM.

Expert Opin Pharmacother. 2005 Oct;6(13):2257-69. Review.

PMID:
16218886
9.

Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus.

Tacconelli E, Cataldo MA, Albanese A, Tumbarello M, Arduini E, Spanu T, Fadda G, Anile C, Maira G, Federico G, Cauda R.

J Hosp Infect. 2008 Aug;69(4):337-44. doi: 10.1016/j.jhin.2008.04.032. Epub 2008 Jul 7.

PMID:
18602187
10.

Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in a Greek tertiary care hospital, over an 8-year-period.

Pantazatou A, Papaparaskevas J, Stefanou I, Papanicolas J, Demertzi E, Avlamis A.

Int J Antimicrob Agents. 2003 Jun;21(6):542-6.

PMID:
12791467
11.

Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients.

Silvestri L, Milanese M, Oblach L, Fontana F, Gregori D, Guerra R, van Saene HK.

Am J Infect Control. 2002 Nov;30(7):391-9.

PMID:
12410215
12.

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE; Joint Working Party of the British Society for Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association.

J Antimicrob Chemother. 2006 Apr;57(4):589-608. Epub 2006 Feb 28. Review.

13.
14.

Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.

Henderson DK.

Am J Infect Control. 2006 Jun;34(5 Suppl 1):S46-54: discussion S64-73. Review.

PMID:
16813982
15.
17.

Epidemiology of staphylococcal resistance.

Shorr AF.

Clin Infect Dis. 2007 Sep 15;45 Suppl 3:S171-6. Review.

19.

Risk factors and associated problems in the management of infections with methicillin resistant Staphylococcus aureus.

Srinivasan S, Sheela D; Shashikala, Mathew R, Bazroy J, Kanungo R.

Indian J Med Microbiol. 2006 Jul;24(3):182-5.

20.

Control of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in hospitalized children.

Fisher MC.

Pediatr Infect Dis J. 1998 Sep;17(9):825-6. No abstract available.

PMID:
9779772
Items per page

Supplemental Content

Write to the Help Desk